BCIwiki (bciwiki.com) — Neuracle Medical Technology (Shanghai) Co., Ltd. has initiated a clinical trial to evaluate the safety and efficacy of its implantable wireless brain-computer interface (BCI) system NEO in patients with tetraplegia. The trial is registered on ClinicalTrials.gov under identifier NCT06990412 and has been completed.
The NEO system is a minimally invasive wireless implantable BCI designed to enable patients to control external devices with brain signals, aiming to improve their quality of life. The trial covers patients with tetraplegia and spinal cord injuries, is conducted in China, and its primary purpose is to provide a basis for product registration.